MoneyWorks4Me

Marksans Pharma - Quaterly Results

13 Aug 2026 Evaluate
The quarter ended June 2026 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 3211.87 millions.An average growth of 43.66% was recorded for the quarter ended June 2026 to Rs. 690.37  millions from Rs. 480.56 millions.The company reported a good operating profit of 995.74 millions compared to 720.64 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3211.87 3197.34 0.45 3211.87 3197.34 0.45 13414.76 11743.74 14.23
Other Income 174.70 20.10 769.15 174.70 20.10 769.15 1035.33 657.87 57.38
PBIDT 995.74 720.64 38.17 995.74 720.64 38.17 4271.00 2738.85 55.94
Interest 3.40 3.02 12.58 3.40 3.02 12.58 13.27 11.74 13.03
PBDT 992.34 717.62 38.28 992.34 717.62 38.28 4257.73 2727.11 56.13
Depreciation 87.76 81.88 7.18 87.76 81.88 7.18 342.30 294.52 16.22
PBT 904.58 635.74 42.29 904.58 635.74 42.29 3915.43 2432.59 60.96
TAX 214.21 155.18 38.04 214.21 155.18 38.04 908.45 549.87 65.21
Deferred Tax 0.41 9.80 -95.82 0.41 9.80 -95.82 45.54 28.43 60.18
PAT 690.37 480.56 43.66 690.37 480.56 43.66 3006.98 1882.72 59.71
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 453.16 0.00
PBIDTM(%) 31.00 22.54 37.55 31.00 22.54 37.55 31.84 23.32 36.52

Marksans Pharma Share Price

333.00 29.80 (9.83%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: